{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:05:51Z","timestamp":1784019951705,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,14]],"date-time":"2027-07-14T00:00:00Z","timestamp":1815523200000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013915","name":"Sarnoff Cardiovascular Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cardfail.2025.08.020","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:03:37Z","timestamp":1764432217000},"page":"1246-1256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Refining Atrial Shunt Therapy for Heart Failure With Preserved Ejection Fraction: Lessons From Pivotal Randomized Trials and Emerging Directions"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-0442","authenticated-orcid":false,"given":"DYLAN J.","family":"GYBERG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN","family":"KOMTEBEDDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UMA","family":"MYLAVARAPU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHELDON E.","family":"LITWIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARTIN B.","family":"LEON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DONALD E.","family":"CUTLIP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SCOTT D.","family":"SOLOMON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RANDALL C.","family":"STARLING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAJA","family":"CIKES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BARRY A.","family":"BORLAUG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID M.","family":"KAYE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GERD","family":"HASENFU\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5655-8201","authenticated-orcid":false,"given":"SANJIV J.","family":"SHAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.08.020_bib0001","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0002","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0004","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0005","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0006","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","author":"Borlaug","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0007","first-page":"237","article-title":"Mitral Stenosis & interauricular communication","volume":"9","author":"Lutembacher","year":"1916","journal-title":"Arch Mal Coeur"},{"issue":"6","key":"10.1016\/j.cardfail.2025.08.020_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.shj.2022.100090","article-title":"Update on atrial shunt therapy for treatment of heart failure","volume":"6","author":"Litwin","year":"2022","journal-title":"Structural Heart"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0009","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.117.032094","article-title":"Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): a phase 2, randomized, sham-controlled trial","volume":"137","author":"Feldman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0011","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","article-title":"Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure","volume":"145","author":"Borlaug","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.amjcard.2014.04.011","article-title":"Effects of healthy aging on the cardiopulmonary hemodynamic response to exercise","volume":"114","author":"van Empel","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0013","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.jacc.2019.08.1062","article-title":"Effects of interatrial shunt on pulmonary vascular function in heart failure with preserved ejection fraction","volume":"74","author":"Obokata","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cardfail.2025.08.020_bib0014","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jchf.2024.04.011","article-title":"2-year outcomes of an atrial shunt device in HFpEF\/HFmrEF: results From REDUCE LAP-HF II","volume":"12","author":"Gustafsson","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.cardfail.2025.08.020_bib0015","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jacc.2006.04.099","article-title":"Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction","volume":"48","author":"Lieberman","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1412283","article-title":"Pacemaker-induced atrial fibrillation reconsidered-associations with different pacing sites and prevention approaches","volume":"11","author":"Kreimer","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jamacardio.2024.0520","article-title":"Atrial shunt device effects on cardiac structure and function in heart failure with preserved ejection fraction: the REDUCE LAP-HF II randomized clinical trial","volume":"9","author":"Patel","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0018","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.124.070870","article-title":"Interatrial shunt treatment for heart failure: the randomized RELIEVE-HF Trial","volume":"150","author":"Stone","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0019","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ahj.2024.08.014","article-title":"Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials","volume":"278","author":"Litwin","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJMcp2305181","article-title":"Heart failure with preserved ejection fraction","volume":"392","author":"Cannata","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0021","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jchf.2023.01.030","article-title":"Exercise-induced left atrial hypertension in heart failure with preserved ejection fraction","volume":"11","author":"Litwin","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0022","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cardfail.2014.01.005","article-title":"Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure","volume":"20","author":"Kaye","year":"2014","journal-title":"J Cardiac Failure"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0023","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","article-title":"A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial","volume":"387","author":"Hasenfu\u00df","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0024","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cardfail.2024.05.008","article-title":"Moving toward understanding the \"hole\" story in HFpEF","volume":"30","author":"Nanayakkara","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0025","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","article-title":"Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure","volume":"145","author":"Borlaug","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0026","article-title":"Atrial shunt therapy for heart failure: an update","volume":"2","author":"Jagadeesan","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0027","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4244\/EIJ-D-19-00342","article-title":"The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction","volume":"15","author":"Paitazoglou","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0028","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ejhf.2119","article-title":"One-year results of the first-in-man study investigating the <scp>Atrial Flow Regulator<\/scp>for left atrial shunting in symptomatic heart failure patients: the <scp>PRELIEVE<\/scp>study","volume":"23","author":"Paitazoglou","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0029","first-page":"1369","article-title":"Left atrial to coronary sinus shunting for treatment of symptomatic heart failure","volume":"16","author":"Hibbert","year":"2023","journal-title":"JACC: Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2025.08.020_bib0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jchf.2023.01.024","article-title":"No-implant interatrial shunt for HFpEF: 6-month outcomes from multicenter pilot feasibility studies","volume":"11","author":"Udelson","year":"2023","journal-title":"JACC Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425004361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425004361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:25:21Z","timestamp":1784017521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425004361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1071916425004361"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.08.020","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining Atrial Shunt Therapy for Heart Failure With Preserved Ejection Fraction: Lessons From Pivotal Randomized Trials and Emerging Directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}